GAD and IA-2 autoantibody detection in type 1 diabetic patient saliva
Some attempts have been made in assaying glutamic-acid decarboxylase autoantibodies (GADA) in type 1 diabetic patient (T1DM) saliva. However, these salivary assays did not show sufficient sensitivity and specificity in comparison to serum assays. In this study we evaluated the ability of a fluid-pha...
Ausführliche Beschreibung
Bibliographische Detailangaben
| Veröffentlicht in: | Clinical immunology (Orlando, Fla.). - 1999. - 131(2009), 2 vom: 02. Mai, Seite 271-6
|
|---|
| 1. Verfasser: |
Tiberti, Claudio
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Shashaj, Blegina,
Verrienti, Antonella,
Vecci, Elio Giancarlo,
Lucantoni, Federica,
Masotti, Donata,
Morano, Susanna,
Sulli, Nicoletta,
Dotta, Francesco |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | English |
|---|
| Veröffentlicht: |
2009
|
|---|
| Zugriff auf das übergeordnete Werk: | Clinical immunology (Orlando, Fla.)
|
|---|
| Schlagworte: | Journal Article
Research Support, Non-U.S. Gov't
Autoantibodies
ICA512 autoantibody
Glutamate Decarboxylase
EC 4.1.1.15 |
|---|